These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20517537)

  • 21. Updates in pediatric endocrinology.
    Kamboj MK
    Adolesc Med State Art Rev; 2013 Apr; 24(1):108-32, xii. PubMed ID: 23705521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiating and intensifying insulin therapy for type 2 diabetes: why, when, and how.
    Cobble ME
    Am J Ther; 2009; 16(1):56-64. PubMed ID: 19142156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug treatment of type 2 diabetes in adults.
    Lowey A
    Nurs Stand; 2005 Nov 23-29; 20(11):55-64; quiz 66. PubMed ID: 16320965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel therapies in diabetes mellitus.
    Bandyopadhyay P
    Drug News Perspect; 2006 Oct; 19(8):499-507. PubMed ID: 17160152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes mellitus in the next decade: novel pipeline medications to treat hyperglycemia.
    Fonseca V
    Clin Ther; 2013 May; 35(5):714-23. PubMed ID: 23688536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic cardiovascular disease lost in translation between endocrinology and cardiology.
    Dagdelen S
    Am J Cardiol; 2008 Oct; 102(8):1115-6. PubMed ID: 18929722
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral hypoglycemic agents? Negative.
    Chalmers TC
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():32-4; discussion 35-6. PubMed ID: 1347537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic management of the patient with type 2 diabetes.
    Quinn L
    Nurs Clin North Am; 2001 Jun; 36(2):217-42, vi. PubMed ID: 11382561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diabetologist/cardiologist debate: a meeting of the minds.
    Mohamed F; Aalbers J
    Cardiovasc J Afr; 2012 Mar; 23(2):115-7. PubMed ID: 22447480
    [No Abstract]   [Full Text] [Related]  

  • 30. Deal watch: Metabolex and Sanofi-Aventis partner on GPCR agonists for type 2 diabetes.
    Nat Rev Drug Discov; 2010 Sep; 9(9):670. PubMed ID: 20811370
    [No Abstract]   [Full Text] [Related]  

  • 31. Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Apr; 7(17):24871-9. PubMed ID: 27029076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 2.
    Tseng CH
    J Diabetes; 2014 Sep; 6(5):448-50. PubMed ID: 24646421
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of type 2 diabetes mellitus with oral antihyperglycaemic therapy.
    Desai A; Tandon N
    Natl Med J India; 2007; 20(4):192-8. PubMed ID: 18085125
    [No Abstract]   [Full Text] [Related]  

  • 34. New advances in the management of insulin resistance in type 2 diabetes. Introduction.
    Campbell IW; Charbonnel B
    Int J Clin Pract Suppl; 2001 Sep; (121):3. PubMed ID: 11594242
    [No Abstract]   [Full Text] [Related]  

  • 35. Current and Emerging Pharmacotherapies for Type 2 Diabetes.
    Lau DC
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S127-8. PubMed ID: 26653252
    [No Abstract]   [Full Text] [Related]  

  • 36. Understanding insulin in day-to-day practice.
    Poole R; Krentz AJ
    Practitioner; 2001 Apr; 245(1621):324-6, 330, 332 passim. PubMed ID: 11332006
    [No Abstract]   [Full Text] [Related]  

  • 37. European Association for the Study of Diabetes--43rd Annual Meeting. Therapeutic approaches: Part 1. 18-21 September 2007, Amsterdam, the Netherlands.
    Toft AD
    IDrugs; 2007 Nov; 10(11):765-8. PubMed ID: 17968753
    [No Abstract]   [Full Text] [Related]  

  • 38. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ; Weiland F
    Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
    [No Abstract]   [Full Text] [Related]  

  • 39. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent and emerging therapeutic medications in type 2 diabetes mellitus: incretin-based, Pramlintide, Colesevelam, SGLT2 Inhibitors, Tagatose, Succinobucol.
    Lo MC; Lansang MC
    Am J Ther; 2013; 20(6):638-53. PubMed ID: 20838206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.